Champions oncology, inc. (CSBR)
CashFlow / Quarterly
Jan'20Oct'19Jul'19Apr'19Jan'19Oct'18Jul'18Apr'18Jan'18Oct'17Jul'17Apr'17Jan'17Oct'16Jul'16Apr'16Jan'16Oct'15Jul'15Jul'14Apr'14Jan'14Oct'13Jul'13Apr'13Jan'13Oct'12Jul'12Apr'12Jan'12Oct'11Jul'11Apr'11Jan'11Oct'10Jul'10
Operating activities:
Net income

406

307

-641

-253

-369

268

482

-632

-76

-94

-674

-2,424

-1,408

-504

-2,546

-2,573

-2,411

-2,547

-2,913

-3,548

-2,272

-578

-2,324

-2,232

-2,046

-987

-1,974

-1,323

-2,550

-1,724

-2,350

-2,037

-2,742

-415

-54

-591

Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation

229

77

131

138

335

88

75

156

137

147

564

761

237

535

1,129

509

567

748

775

808

839

940

476

552

442

570

625

739

711

744

854

1,014

1,555

1,211

197

170

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

155

237

846

-586

-1,462

-53

-254

-52

285

63

66

111

177

-36

0

0

0

Provision for (recovery of) doubtful accounts

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2

-3

-1

34

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock for services

0

0

0

-2

0

0

8

15

-15

30

0

24

5

0

15

44

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization expense

219

178

182

173

164

151

118

107

121

90

42

41

40

42

45

42

38

39

37

56

-

-

-

50

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

49

54

40

16

20

29

12

10

10

10

Operating lease right-of use assets

101

100

98

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Provision for doubtful accounts

184

28

6

-

53

0

0

-

41

-55

14

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

0

0

0

-

-63

-65

-151

-

-151

-151

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

759

55

-480

476

-731

934

-148

931

406

-144

407

272

137

263

314

-796

213

467

398

-400

-1,798

1,661

-322

1,284

-

-

-

-

-

-

-

-

-

-

-

-

Grant receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-13

150

-593

960

0

Prepaid expenses and other current assets

-8

107

-52

10

36

16

-41

102

-118

-57

60

-241

95

97

-94

29

119

-71

20

73

102

62

-37

-59

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-13

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

55

87

-335

-404

651

174

30

302

-13

Prepaid expenses, deposits and other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

107

-230

-13

65

-97

122

-133

-109

Accounts payable

-572

-259

-82

699

95

-98

-43

177

427

-183

-120

529

172

-357

-387

381

177

-98

22

347

43

-46

7

-227

102

-107

-82

-385

53

329

-204

-82

-503

701

273

165

Accrued liabilities

137

71

-410

539

300

-25

-203

230

-25

-161

-134

357

24

82

-51

14

-26

-133

43

-196

-118

376

-12

-270

44

53

170

-281

281

121

-41

-38

129

-44

-66

43

Operating lease liabilities

114

105

42

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

440

177

-53

-

-105

565

-441

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-current liability

-

-

-

-

-

-

-

-

-

-

-

-64

0

0

20

1

29

35

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

853

-28

142

-1,173

1,288

478

447

-442

264

1,233

-265

-102

-427

-4

136

1,099

-254

97

-188

287

-267

-316

-398

-178

459

1,247

-214

19

-355

Net cash provided by operating activities

279

360

-279

252

1,210

64

336

9

445

268

-1,948

398

-683

-116

-2,439

-555

-726

-2,584

-2,543

-

-

-

-

-

-

-

-748

-1,806

-1,523

-413

-1,756

-1,535

-558

1,690

-750

-436

Investing activities:
Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,788

-

-

-

-2,144

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of property and equipment

171

-227

749

141

207

275

211

212

75

32

910

585

151

13

17

146

132

15

29

33

70

88

36

40

22

7

9

19

148

211

65

95

38

22

5

20

Net cash used in investing activities

-171

227

-749

-141

-207

-275

-211

-209

-75

-32

-910

-585

-151

-13

-17

-146

-132

-15

-29

-

-

-

-

-

-

-

-9

-19

-148

-211

-65

-95

-37

-22

-5

-20

Financing activities:
Proceeds from June 2016 Public Offering, net of financing costs of $742

-

-

-

-

-

-

-

-

-

-

-

0

0

0

4,340

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of options and warrants

427

2

0

-

364

1,034

42

-

38

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Private placement financing, net of financing costs of $880k

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-33

-

-

-

-40

-

-

-

-

-

-

-

-

-

-

-

-

Payment of issuance costs related to March 2015 Private Placement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

18

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Finance lease payments

37

7

7

209

13

33

7

6

6

6

7

6

6

6

6

7

6

4

7

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of treasury stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

960

0

42

31

Proceeds from exercise of options and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-1

0

94

4

19

2

0

0

Net cash provided by financing activities

390

-5

-7

-184

351

1,001

35

-6

32

-6

-7

-6

-6

-6

4,334

-7

-6

-4

-25

-

-

-

-

-

-

-

0

0

-1

0

94

4

8,154

2

-42

-31

Increase in cash

498

582

-1,035

-73

1,354

790

160

-206

402

230

-2,865

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash investing activities:
Right-of-use assets obtained in exchange for operating lease liabilities

-

-

3,205

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used in)/provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Exchange rate effect on cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-18

3

-7

-8

-12

0

-2

2

25

-56

-13

7

8

-43

8

-28

3

(Decrease)/Increase in cash and cash equivalents.

-

-

-

-

-

-

-

-

-

-

-

-193

-840

-135

1,878

-708

-864

-2,603

-2,597

-2,839

79

-1,760

207

-2,196

-1,246

8,608

-755

-1,800

-1,728

-637

-1,720

-1,618

7,516

1,678

-825

-484

Purchase equipment under finance lease

212

0

0

0

0

-14

249

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-